[
    "{\"step_by_step_thinking\": \"Benralizumab is a monoclonal antibody that is used in the treatment of various conditions. However, according to Document [0], the role of Benralizumab in chronic spontaneous urticaria (CSU) is unclear. It may improve CSU in some patients, but it may worsen CSU in others. Document [1] also mentions that data are too limited so far to clearly define the role of Benralizumab in CSU. Therefore, it cannot be definitively stated that Benralizumab is effective for CSU.\", \"answer_choice\": \"B. no\"}"
]